Newbury's Generic Version of Resolor Gets Marketing Authorization in Sweden

MT Newswires · 2d ago
01:06 PM EDT, 10/27/2026 (MT Newswires) -- Newbury Pharmaceuticals (NEWBRY.ST) secured Swedish marketing authorization for Prukalopride Newbury, a generic version of Resolor, for the symptomatic treatment of chronic constipation in adults. The authorization covers the pharmaceutical company's drug in 1-milligram and 2-mg film-coated tablets, according to a Tuesday release. The company has no plans for further country approvals at this time.